Tag: Vaccines
Pfizer’s Updated Booster Targets Omicron Variants, New Data Confirm
Recipients showed 'a substantial increase' in their neutralizing antibody response against the two omicron subvariants, BA.5 and BA.5
FDA Approves New Bivalent COVID-19 Booster for Use in Children
Moderna vaccine is authorized for children down to 6 years old, while Pfizer-BioNTech vaccine is approved for children as young as 5 years
FDA Approves Boostrix for Third-Trimester Administration
Approval is specifically for use during pregnancy to prevent pertussis in infants whose mothers are vaccinated during pregnancy
Pollution Tied to Risk for Serious COVID-19 Despite Vaccination
Exposures to PM2.5 and NO2 linked to increased risk for COVID-19-related hospitalization, with and without adjustment for vaccination
Fourth Vaccination Ups Immunity to Omicron Variants in Cancer Patients
Humoral response seen in patients receiving B cell-targeted therapy for hematologic malignancy, patients with solid malignancies
COVID-19 Boosters Could Save 90,000 Lives This Winter
Updated booster doses could also prevent more than 936,000 hospitalizations and save $56 billion in six months
Infections Reported After Single Dose of Monkeypox Vaccine
Most of the cases of monkeypox occurring following single dose of the MVA-BN vaccine occur within 14 days
Bivalent mRNA-1273.214 Elicits Better Response Against Omicron
Booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, with no new safety concerns
Pfizer, Moderna Seek Approval of New COVID-19 Boosters for Children
'Bivalent' shots target both the original coronavirus and the omicron BA.4 and BA.5 subvariants
Total Number of HPV Vaccination Encounters Down During Pandemic
However, there was an increase seen in vaccinations per encounter, with seasonal variation
